Novo
0 sources
Summary
Novo is a business[1]. Novo ranks in the top 0.82% of business entities by monthly Wikipedia readership (19,610 views/month, #243 of 29,529).[2]
Key Facts
- Novo was a member of C40 Cities Climate Leadership Group[3].
- Novo is in the country of Denmark[4].
- Novo's instance of is recorded as business[5].
- Novo's instance of is recorded as enterprise[6].
- Novo's instance of is recorded as public company[7].
- Novo's instance of is recorded as biopharmaceutical company[8].
- Novo's founder is recorded as Hans Christian Hagedorn[9].
- Novo's founder is recorded as August Krogh[10].
- Novo's founder is recorded as Marie Krogh[11].
- Novo's founder is recorded as August Kongsted[12].
- Novo is owned by Novo Holdings[13].
- Novo is owned by Novo Nordisk Foundation[14].
- Novo's headquarters location is recorded as Bagsværd[15].
- Novo's chief executive officer is recorded as Lars Fruergaard Jørgensen[16].
- Novo's chief executive officer is recorded as Mike Doustdar[17].
- Novo's child organization or unit is recorded as Novo Nordisk (United States)[18].
- Novo's child organization or unit is recorded as Novo Nordisk (Switzerland)[19].
- Novo's child organization or unit is recorded as Novo Nordisk (Germany)[20].
- Novo's child organization or unit is recorded as Novo Nordisk s.r.o.[21].
- Novo's child organization or unit is recorded as Novo Nordisk (Algeria)[22].
- Novo's child organization or unit is recorded as NNE A/S[23].
- Novo's Commons category is recorded as Novo Nordisk[24].
- Novo's stock exchange is recorded as New York Stock Exchange[25].
- Novo's stock exchange is recorded as Nasdaq Copenhagen A/S[26].
- Novo's industry is recorded as pharmaceutical industry[27].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300DAQ1CVT6CXN342[28]
-
Registered legal name: Novo Nordisk A/S[29]
-
Legal jurisdiction: DK[30]
-
GLEIF entity category: GENERAL[31]
-
Legal form (ISO 20275 ELF): ZRPO[32]
-
Entity status: ACTIVE[33]
-
LEI registration status: ISSUED[34]
-
Entity created: 1931-11-28[35]
-
LEI first registered: 2013-09-10[36]
-
LEI last updated: 2025-12-22[37]
-
LEI next renewal: 2027-02-07[38]
-
Managing LOU: 549300O897ZC5H7CY412[39]
-
Registration authority: RA000170[40]
-
Authority entity ID: 24256790[41]
-
Conformity flag: CONFORMING[42]
Body
Founding
Founders include Hans Christian Hagedorn[9], August Krogh[10], Marie Krogh[11], and August Kongsted[12]. January 1, 1923 marks the founding of Novo[43].
Identity
Novo's official name is recorded as {'lang': 'da', 'text': 'Novo Nordisk'}[44].
Leadership
Chief executives include Lars Fruergaard Jørgensen[16], a director[45], b. 1966[46], of Kingdom of Denmark[47], awarded the Knight of the Order of the Dannebrog[48] and Mike Doustdar[17], a businessperson[49], b. 1970[50], of Austria[51], specialised in pharmacy[52].
Operations
Novo's headquarters location is recorded as Bagsværd[15]. Novo's parent organization or unit is recorded as Novo Holdings[53]. Subsidiaries include Novo Nordisk (United States)[18], a business[54], in United States[55], founded in 1923[56], headquartered in Seattle[57]; Novo Nordisk (Switzerland)[19]; Novo Nordisk (Germany)[20], a business[58], in Germany[59], founded in 1973[60], headquartered in Mainz[61]; Novo Nordisk s.r.o.[21], a business[62], in Czech Republic[63], founded in 1997[64], headquartered in Prague[65]; Novo Nordisk (Algeria)[22]; and NNE A/S[23], a business[66], in Denmark[67], founded in 1991[68], headquartered in Virum[69].
Industry
Novo's industry is recorded as pharmaceutical industry[27].
Ownership
Owners include Novo Holdings[13], a business[70], in Denmark[71], founded in 1999[72], headquartered in Gentofte Municipality[73] and Novo Nordisk Foundation[14], a foundation[74], in Denmark[75], founded in 1989[76], headquartered in Hellerup[77]. Stock exchanges include New York Stock Exchange[25] and Nasdaq Copenhagen A/S[26]. Products include preproinsulin[78], glucagon-like peptide-1 agonist[79], glucagon[80], growth hormone[81], sex steroid[82], and semaglutide[83].
Brands and Namesakes
Things named for Novo include Novo Nordisk Prize[84], a science award[85], in Denmark[86], founded in 1963[87].
Why It Matters
Novo ranks in the top 0.82% of business entities by monthly Wikipedia readership (19,610 views/month, #243 of 29,529).[2] Novo has Wikipedia articles in 25 language editions, a strong signal of global cultural recognition.[88] Novo is known by 20 alternative names across languages and contexts.[89]
Entities named for Novo include Novo Nordisk Prize[84], a science award[85], in Denmark[86], founded in 1963[87].